PCN188 - ASSESSING THE ROBUSTNESS OF A COST-EFFECTIVENESS ANALYSIS OF LENVATINIB VERSUS SORAFENIB IN UNRESECTABLE HEPATOCELLULAR CARCINOMA IN JAPAN
Autor: | Ikeda, S., Kudo, M., Izumi, N., Kaneko, S., Kobayashi, M., Azuma, M., Copher, R., Virabhak, S., Mitchell, D., Meier, G., Ishii, M. |
---|---|
Zdroj: | In Value in Health October 2018 21 Supplement 3:S46-S46 |
Databáze: | ScienceDirect |
Externí odkaz: |